4 ms·
So one thing I will add, you might want to approach the companies that are at the top of the list and offer them the tool as a sale tool. But overall, the goal
by streetcat1 7y ago
So one thing I will add, you might want to approach the companies that are at the top of the list and offer them the tool as a sale tool.
But overall, the goal of health care as a commercial Endover is to keep you sick (I.e., not healthy, since then you will not spend, and not dead).
So the goal of selling to health care professionals is actually the opposite of your goal of helping patients.
- jcims 7y agoI think this is overstated most of the time, otherwise why would we have vaccines? However, I would be on board with saying that when situations get dire, risk management begins to diverge incentives between patients and providers.
- lonelappde 7y agoVaccines exist for a tiny fraction of conditions. And in the market consumers revealed preference is for $1000/yr treatment over $20K vaccine, or equivalent multiples. When a new vaccine is invented, people balk at the price and complain it shouldn't have been created. Far more investment is in "managing" conditions.
- sangnoir 7y agoI don't buy this line of thinking - the list of curable diseases/conditions is longer than the incurable ones. Selection bias means the incurable ones get more attention (because they have to be managed). The health care industry is (mostly) not a coordinated cartel; it's a bunch of self-interested organizations looking to get a leg-up on the competition.
- qroshan 7y agoYeah it's dumb. A Cure will instantly make any product 10000x more valuable because it can be sold across the globe while care is very much limited to local hospitals. Even the incentive system doesn't add up. It's as dumb as claiming that the cure for baldness is not invented because of the hat / wig / hair-transplant cartel that want's to keep you bald